• Je něco špatně v tomto záznamu ?

Introducing a new prognostic instrument for long-term mortality prediction in COPD patients: the CADOT index

K. Brat, M. Svoboda, K. Hejduk, M. Plutinsky, J. Zatloukal, E. Volakova, P. Popelkova, B. Novotna, D. Engova, F. M. E. Franssen, L. E. G. W. Vanfleteren, M. A. Spruit, V. Koblizek

. 2021 ; 165 (2) : 139-145. [pub] 20200910

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22007869

OBJECTIVES: The BODE (BMI, Obstruction - FEV1, Dyspnoea - mMRC, Exercise - 6-MWT) and the ADO (Age, Dyspnoea - mMRC, Obstruction - FEV1) indices are widely used prognosis assessment tools for long-term mortality prediction in COPD patients but subject to limitations for use in daily clinical practice. The aim of this research was to construct a prognostic instrument that prevents these limitations and which would serve as a complementary prognostic tool for clinical use in these patients. METHODS AND PARTICIPANTS: The data of 699 COPD subjects were extracted from the Czech Multicentre Research Database (CMRD) of COPD patients (the derivation cohort) and analysed to identify factors associated with the long-term risk of mortality. These were entered into the ROC analysis and reclassification analysis. Those with the strongest discriminative power were used to construct the new index (CADOT). The new index was validated on 187 patients of the CIROCO+ cohort (Netherlands; the validation cohort). RESULTS: The CADOT was constructed by adding two newly identified prognosis-determining factors, chronic heart failure (CHF) and TLCO, to the ADO index. In a head-to-head comparison, the CADOT index showed highest c-statistic values compared to the BODE and ADO indices (0.701 vs 0.677 vs 0.644, respectively). The prognostic power was more definitive when applied to the Dutch validation (CIROCO+) cohort (0.842 vs 0.799 vs 0.825, respectively). CONCLUSIONS: The CADOT index has comparable prognostic power to the BODE and ADO indices. The CADOT is complementary/an alternative to the BODE (if 6-MWT is not feasible) and ADO (with less dependence on the age factor) indices. TRIAL REGISTRATION: ClinicalTrials.gov (NCT01923051).

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc22007869
003      
CZ-PrNML
005      
20220401110851.0
007      
ta
008      
220309s2021 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2020.035 $2 doi
035    __
$a (PubMed)32955038
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Brat, Kristián $7 xx0224637 $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
245    10
$a Introducing a new prognostic instrument for long-term mortality prediction in COPD patients: the CADOT index / $c K. Brat, M. Svoboda, K. Hejduk, M. Plutinsky, J. Zatloukal, E. Volakova, P. Popelkova, B. Novotna, D. Engova, F. M. E. Franssen, L. E. G. W. Vanfleteren, M. A. Spruit, V. Koblizek
504    __
$a Literatura
520    9_
$a OBJECTIVES: The BODE (BMI, Obstruction - FEV1, Dyspnoea - mMRC, Exercise - 6-MWT) and the ADO (Age, Dyspnoea - mMRC, Obstruction - FEV1) indices are widely used prognosis assessment tools for long-term mortality prediction in COPD patients but subject to limitations for use in daily clinical practice. The aim of this research was to construct a prognostic instrument that prevents these limitations and which would serve as a complementary prognostic tool for clinical use in these patients. METHODS AND PARTICIPANTS: The data of 699 COPD subjects were extracted from the Czech Multicentre Research Database (CMRD) of COPD patients (the derivation cohort) and analysed to identify factors associated with the long-term risk of mortality. These were entered into the ROC analysis and reclassification analysis. Those with the strongest discriminative power were used to construct the new index (CADOT). The new index was validated on 187 patients of the CIROCO+ cohort (Netherlands; the validation cohort). RESULTS: The CADOT was constructed by adding two newly identified prognosis-determining factors, chronic heart failure (CHF) and TLCO, to the ADO index. In a head-to-head comparison, the CADOT index showed highest c-statistic values compared to the BODE and ADO indices (0.701 vs 0.677 vs 0.644, respectively). The prognostic power was more definitive when applied to the Dutch validation (CIROCO+) cohort (0.842 vs 0.799 vs 0.825, respectively). CONCLUSIONS: The CADOT index has comparable prognostic power to the BODE and ADO indices. The CADOT is complementary/an alternative to the BODE (if 6-MWT is not feasible) and ADO (with less dependence on the age factor) indices. TRIAL REGISTRATION: ClinicalTrials.gov (NCT01923051).
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a dyspnoe $7 D004417
650    _2
$a lidé $7 D006801
650    _2
$a prognóza $7 D011379
650    12
$a chronická obstrukční plicní nemoc $x mortalita $7 D029424
650    _2
$a respirační funkční testy $7 D012129
650    _2
$a stupeň závažnosti nemoci $7 D012720
655    _2
$a časopisecké články $7 D016428
700    1_
$a Svoboda, Michal $7 xx0230935 $u Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Hejduk, Karel $7 xx0227632 $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Plutinský, Marek $7 xx0255631 $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Zatloukal, Jaromír $7 xx0113000 $u Department of Respiratory Medicine, University Hospital Olomouc, Czech Republic
700    1_
$a Voláková, Eva, $d 1971- $7 xx0223802 $u Department of Respiratory Medicine, University Hospital Olomouc, Czech Republic
700    1_
$a Popelková, Patrice $7 xx0104407 $u Pulmonary Department, University Hospital Ostrava, Czech Republic
700    1_
$a Novotná, Barbora $7 xx0231471 $u Pulmonary Department, Bulovka Hospital, Prague, Czech Republic
700    1_
$a Engová, Dita, $d 1970- $7 xx0271515 $u Boehringer Ingelheim s.r.o., Prague, Czech Republic
700    1_
$a Franssen, Frits M. E. $u Department of Research and Education, CIRO, Center of Expertise for Chronic Organ Failure, Horn, The Netherlands $u Department of Respiratory Medicine, Maastricht University Medical Centre, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands
700    1_
$a Vanfleteren, Lowie E. G. W. $u COPD Center, Sahlgrenska University Hospital, Institute of Medicine, University of Gothenburg, Sweden
700    1_
$a Spruit, Martijn A. $u Department of Research and Education, CIRO, Center of Expertise for Chronic Organ Failure, Horn, The Netherlands $u REVAL Rehabilitation Research Center, BIOMED Biomedical Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium $u Department of Respiratory Medicine, Maastricht University Medical Centre, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands
700    1_
$a Koblížek, Vladimír, $d 1970- $7 xx0076215 $u Pulmonary Department, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Czech Republic
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 165, č. 2 (2021), s. 139-145
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32955038 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20220309 $b ABA008
991    __
$a 20220401110843 $b ABA008
999    __
$a ok $b bmc $g 1775506 $s 1159062
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 165 $c 2 $d 139-145 $e 20200910 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20220309
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace